Seeing Is Believing

Currently out of the existing stock ratings of Lawrence Keusch, 108 are a BUY (96.43%), 4 are a HOLD (3.57%).
Analyst Lawrence Keusch, carries an average stock price target met ratio of 65.83% that have a potential upside of 18.43% achieved within 264 days.
Lawrence Keusch’s has documented 189 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on BDX, Becton Dickinson and Company at 04-Aug-2023.
Analyst best performing recommendations are on HAE (HAEMONETICS).
The best stock recommendation documented was for BDX (BECTON DICKINSON AND COMPANY) at 2/7/2020. The price target of $232.2 was fulfilled within 7 days with a profit of $11.73 (5.32%) receiving and performance score of 7.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$14
$2.89 (26.01%)
$17
5 months 27 days ago
(07-May-2025)
7/9 (77.78%)
$1.42 (11.29%)
111
Hold
$34
2 years 3 months 9 days ago
(25-Jul-2023)
5/10 (50%)
$11.59 (51.72%)
102
Buy
$31
$19.89 (179.03%)
$30
2 years 5 months 12 days ago
(22-May-2023)
6/7 (85.71%)
$7.45 (31.63%)
396
Sell
$24
$-2.79 (-10.41%)
$28
3 years 23 days ago
(11-Oct-2022)
2/4 (50%)
$3.54 (12.24%)
19
Hold
$40
$28.89 (260.04%)
$45
4 years ago
(03-Nov-2021)
3/5 (60%)
$3.98 (11.05%)
100
What Year was the first public recommendation made by Lawrence Keusch?